Diagnoses primary myelofibrosis according to the International Consensus Classification (ICC) criteria published in 2022. This systematic diagnostic framework distinguishes between prefibrotic (early) and overt (fibrotic) stages of primary myelofibrosis using morphological, genetic, and clinical criteria. The ICC criteria refine the WHO classification system by providing better diagnostic specificity for myeloproliferative neoplasms. The diagnosis requires all three major criteria plus at least one minor criterion, confirmed in two consecutive determinations. This classification facilitates accurate diagnosis, appropriate staging, prognostic assessment, and treatment planning for patients with suspected primary myelofibrosis. The tool is particularly valuable for hematologists and pathologists in differentiating PMF from other myeloproliferative neoplasms and establishing precise diagnostic categorization.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The International Consensus Classification (ICC) Diagnostic Criteria for Primary Myelofibrosis (PMF) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Prefibrotic Primary Myelofibrosis
Overt Fibrotic Primary Myelofibrosis
Diagnostic Criteria Not Met
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.